Evidence map›Paper›PMID 9647867›Full record

ReviewPharmacological reviews1998

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

A J Harmar, A Arimura, I Gozes, L Journot, M Laburthe, J R Pisegna, S R Rawlings, P Robberecht, S I Said, S P Sreedharan and 2 more

Abstract readReview
In one paragraph

Review in Pharmacological reviews, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia (International journal of molecular sciences · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A J HarmarMRC Brain Metabolism Unit, Royal Edinburgh Hospital, Scotland, UK. Tony.Harmar@ed.ac.uk
A Arimura
I Gozes
L Journot
M Laburthe
J R Pisegna
S R Rawlings
P Robberecht
S I Said
S P Sreedharan
S A Wank
J A Waschek

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
BLRD VA I01 BX004560NIDDK NIH HHS P30 DK041301RRD VA I01 RX000194
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptors, Pituitary HormoneReceptors, Vasoactive Intestinal PeptideAnimalsHumansReceptors, Pituitary Adenylate Cyclase-Activating PolypeptideTerminology as TopicReceptors, Pituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary HormoneReceptors, Vasoactive Intestinal Peptide

Identifiers

PMID9647867
PMCPMC6721840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.